SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zim Laboratories - Quaterly Results

20 May 2026 Evaluate
A decrease in the sales to Rs. 1028.54 millions was observed for the quarter ended March 2026. The sales stood at Rs. 1085.15 millions during the similar quarter previous year.The Net Profit of the company slipped to Rs. 32.81 millions from Rs. 54.20 millions, a decline of -39.46% on QoQ basis.The company reported a degrowth in operating Profit to 127.35 millions from 167.91 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 1028.54 1085.15 -5.22 3704.82 3756.36 -1.37 3704.82 3756.36 -1.37
Other Income 61.59 15.54 296.33 113.90 56.21 102.63 113.90 56.21 102.63
PBIDT 127.35 167.91 -24.16 409.70 488.90 -16.20 409.70 488.90 -16.20
Interest 33.10 29.09 13.78 132.02 113.86 15.95 132.02 113.86 15.95
PBDT 94.25 138.82 -32.11 277.68 375.04 -25.96 277.68 375.04 -25.96
Depreciation 49.01 52.34 -6.36 193.67 198.91 -2.63 193.67 198.91 -2.63
PBT 45.24 86.48 -47.69 84.01 176.13 -52.30 84.01 176.13 -52.30
TAX 12.43 32.28 -61.49 24.35 58.68 -58.50 24.35 58.68 -58.50
Deferred Tax -5.65 -1.14 395.61 -8.40 14.21 -159.11 -8.40 14.21 -159.11
PAT 32.81 54.20 -39.46 59.66 117.45 -49.20 59.66 117.45 -49.20
Equity 535.00 487.26 9.80 535.00 487.26 9.80 535.00 487.26 9.80
PBIDTM(%) 12.38 15.47 -19.98 11.06 13.02 -15.03 11.06 13.02 -15.03

Zim Laboratories Share Price

108.60 5.15 (4.98%)
09-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1779.40
Dr. Reddys Lab 1268.75
Cipla 1376.75
Zydus Lifesciences 1105.75
Lupin 2263.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×